PROM1 and pancreatic neoplasm: Although its expression in hepatocellular carcinoma cells is not linked with leptin elicited effects, its expression along with other pancreatic cancer stem cell markers (including Oct-4, CD133, CD24/44 and ALDH) is significantly increased in leptin treated pancreatic cancer cells [72].